Gland Pharma IPO vs IRFC IPO

Comparision between Gland Pharma IPO and IRFC IPO.

IPO Details

Gland Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while IRFC IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Gland Pharma IPO	IRFC IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Citigroup Global Markets India Private Limited Haitong Securities India Private Limited Kotak Mahindra Capital Company Limited Nomura Financial Advisory And Securities (India) Pvt Ltd	Hsbc Securities & Capital Markets Pvt Ltd ICICI Securities Limited Idfc Bank Limited SBI Capital Markets Limited
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Gland Pharma IPO is up to ₹6,479.55 Cr whereas the issue size of the IRFC IPO is up to ₹4,633.38 Cr. The final issue price of Gland Pharma IPO is ₹1,500.00 per share and of IRFC IPO is ₹26.00 per share.

	Gland Pharma IPO	IRFC IPO
Face Value	₹1 per share	₹10 per share
Issue Price (Lower)	₹1,490.00 per share	₹25.00 per share
Issue Price (Upper)	₹1,500.00 per share	₹26.00 per share
Issue Price (Final)	₹1,500.00 per share	₹26.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	10 shares	575 shares
Fresh Issue Size	83,33,333 shares	1,18,80,46,000 shares
Fresh Issue Size (Amount)	up to ₹1,250.00 Cr
OFS Issue Size	3,48,63,635 shares	59,40,23,000 shares
OFS Issue Size (Amount)	up to ₹5,229.55 Cr
Issue Size Total	4,31,96,968 shares	1,78,20,69,000 shares
Issue Size Total (Amount)	up to ₹6,479.55 Cr	up to ₹4,633.38 Cr

IPO Timetable

Gland Pharma IPO opens on Nov 09, 2020, while IRFC IPO opens on Jan 18, 2021. The closing date of Gland Pharma IPO and IRFC IPO is Nov 11, 2020, and Jan 20, 2021, respectively.

	Gland Pharma IPO	IRFC IPO
Anchor Bid Date
Issue Open	Nov 09, 2020	Jan 18, 2021
Issue Close	Nov 11, 2020	Jan 20, 2021
Basis Of Allotment (Tentative)	Nov 17, 2020	Jan 25, 2021
Initiation of Refunds (Tentative)	Nov 18, 2020	Jan 27, 2021
Credit of Share (Tentative)	Nov 19, 2020	Jan 28, 2021
Listing date (Tentative)	Nov 20, 2020	Jan 29, 2021
Anchor Lockin End date 1	Dec 17, 2020	Feb 24, 2021
Anchor Lockin End date 2	Feb 15, 2021	Apr 25, 2021

Financials

Gland Pharma IPO P/E ratio is , as compared to IRFC IPO P/E ratio of .

Gland Pharma IPO

IRFC IPO

Financial

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (Rs in million)
	30-June-20	31-Mar-20	31-Mar-19	31-Mar-18
Total Assets	46,912.65	40,860.39	35,235.49	29,294.68
Total Revenue	9,162.89	27,724.08	21,297.67	16,716.82
Profit After Tax	3,135.90	7,728.58	4,518.56	3,210.51

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (Rs in million)
	30-Sep-20	31-Mar-20	31-Mar-19	31-Mar-18
Total Assets	29,19,865.81	27,55,041.29	20,64,382.95	16,14,510.41
Total Revenue	73,848.29	1,34,210.90	1,09,873.55	92,078.39
Profit After Tax	18,868.41	31,920.96	21,399.33	20,014.60

Promoter Shareholding (Pre-Issue)

74%

100%

Promoter Shareholding (Post-Issue)

58%

86%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Gland Pharma IPO retail investors (RII) are offered 1,51,18,939 shares while in IRFC IPO retail investors are offered 1,51,18,939 shares. Qualified institutional buyers (QIB) are offered 86,39,394 shares in Gland Pharma IPO and 35,63,75,339 shares in IRFC IPO.

	Gland Pharma IPO	IRFC IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	86,39,394 shares	35,63,75,339 shares
NII	64,79,546 shares	26,72,81,504 shares
RII	1,51,18,939 shares	62,36,56,843 shares
Employee	0 shares	1,92,307 shares
Others
Total	3,02,37,879 shares	1,24,75,05,993 shares

Bids Received (Subscription)

Gland Pharma IPO subscribed 2.06x in total, whereas IRFC IPO subscribed 3.49x.

	Gland Pharma IPO	IRFC IPO
QIB (times)	6.40x	3.78x
NII (times)	0.51x	2.67x
Big NII (times)
Small NII (times)
RII (times)	0.24x	3.66x
Employee (times)		43.76x
Other (times)
Total (times)	2.06x	3.49x

Compare with others

Gland Pharma IPO	IRFC IPO
Antony Waste IPO	Stove Kraft IPO
Mrs. Bectors Food IPO	Home First Finance IPO
IRFC IPO	Indigo Paints IPO
Burger King IPO	Antony Waste IPO
RailTel IPO	Mrs. Bectors Food IPO
Mazagon Dock IPO	Burger King IPO
Likhitha Infrastructure IPO	RailTel IPO
Chemcon IPO	Gland Pharma IPO
Route Mobile IPO	Mazagon Dock IPO
Angel One IPO	Likhitha Infrastructure IPO

Comments

Add a public comment...